DHC Short Take: Dr. Sara Farag, Sermo Medical Advisory Board
This conversation between Mark Bard and Sara Farag, MD FACOG of the Sermo Medical Advisory Board, highlights the evolving dynamics of rep interactions, transitioning from in-person to digital during COVID and now incorporating both methods post-COVID.
Dr. Farag emphasizes the value of rep interactions for staying updated on new medications/tools, establishing relationships, and accessing resources like medical liaisons and patient support tools.
Dr. Farag shares her perspective on how digital communication complements traditional interactions, enhancing efficiency by allowing her to access information and benefiting from tailored approaches to pharma-led physician education and support.
Thank you for Dr Farag for sharing your insights